🇺🇸 FDA
Patent

US 7786221

Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules

granted A61KA61K47/60

Quick answer

US patent 7786221 (Multi-armed, monofunctional, and hydrolytically stable derivatives of poly (ethylene glycol) and related polymers for modification of surfaces and molecules) held by Nektar Therapeutics expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K47/60